Enclosed herewith Compliance Certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 for the March Quarter and Year Ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivanza Biosciences has submitted a routine compliance certificate under SEBI's Depositories and Participants Regulations for the quarter and year ended 31 March 2026. The certificate was issued by Purva Sharegistry (India) Pvt Ltd, the company's Registrar and Share Transfer Agent, confirming that all share certificates received for dematerialization during the quarter were duly processed and the company's name in the depository records was updated within prescribed timelines. The attached details show NIL share certificates were dematerialized between 1 January 2026 and 31 March 2026, meaning no shareholder converted physical shares into demat form during the quarter. This is a standard quarterly regulatory filing required of all listed companies and contains no business or financial information.
No impact on shareholders or stock price. This is a purely procedural compliance submission confirming routine depository activities, with no corporate action, financial change, or material event involved.